Skip to Main content Skip to Navigation
Journal articles

Metal chelators for the inhibition of the lymphocytic choriomeningitis virus endonuclease domain

Abstract : Arenaviridae is a viral family whose members are associated with rodent-transmitted infections to humans responsible of severe diseases. The current lack of a vaccine and limited therapeutic options make the development of efficacious drugs of high priority. The cap-snatching mechanism of transcription of Arenavirus performed by the endonuclease domain of the L-protein is unique and essential, so we developed a drug design program targeting the endonuclease activity of the prototypic Lymphocytic ChorioMeningitis Virus. Since the endonuclease activity is metal ion dependent, we designed a library of compounds bearing chelating motifs (diketo acids, polyphenols, and N-hydroxyisoquinoline-1,3-diones) able to block the catalytic center through the chelation of the critical metal ions, resulting in a functional impairment. We pre-screened 59 compounds by Differential Scanning Fluorimetry. Then, we characterized the binding affinity by Microscale Thermophoresis and evaluated selected compounds in in vitro and in cellula assays. We found several potent binders and inhibitors of the endonuclease activity. This study validates the proof of concept that the endonuclease domain of Arenavirus can be used as a target for anti-arena-viral drug discovery and that both diketo acids and N-hydroxyisoquinoline-1,3-diones can be considered further as potential metal-chelating pharmacophores.
Document type :
Journal articles
Complete list of metadatas

https://hal-amu.archives-ouvertes.fr/hal-02612507
Contributor : Julien Caugant <>
Submitted on : Tuesday, May 19, 2020 - 11:18:33 AM
Last modification on : Tuesday, October 20, 2020 - 3:13:58 AM

Licence


Copyright

Identifiers

Collections

Citation

Magali Saez-Ayala, Elsie Laban Yekwa, Clémence Mondielli, Loic Roux, Sergio Hernández, et al.. Metal chelators for the inhibition of the lymphocytic choriomeningitis virus endonuclease domain. Antiviral Research, Elsevier Masson, 2019, 162, pp.79-89. ⟨10.1016/j.antiviral.2018.12.008⟩. ⟨hal-02612507⟩

Share

Metrics

Record views

36